The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices.The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. United States Politics and Government, Prices (Fares, Fees and Rates), Drugs (Pharmaceuticals), Insulin, Diabetes, Regulation and Deregulation of Industry, Consumer Protection, Express Scripts Inc, Federal Trade Commission, Biden, Joseph R Jr, Trump, Donald J Read More
F.T.C. Settles With Express Scripts Over High Insulin Prices
